April 17, 2026 · Form 4 insider transaction
Rodman David Malcom bought 416 shares of Mineralys Therapeutics, Inc. at $15.44 per share, a transaction worth $6.4K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025.